Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Roussel Morishita reports new aromatase inhibitor

April 5, 1996

Boehringer Mannheim synthesizes antitumor anthrapyrazoles

April 5, 1996

Yakult Honsha claims camptothecin derivatives

April 5, 1996

Sparta to develop new camptothecin formulations

April 5, 1996

New daunorubicin derivative from P&U

April 5, 1996

Spartaject busulfan to enter phase I

April 5, 1996

FDA approves expanded labeling for Ethyol

March 15, 1996

Multidrug resistance modulator from Pfizer

March 15, 1996

Xenova to evaluate MDR modulator in phase I

March 15, 1996

MethylGene established to study antisense drugs for cancer indications

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...